Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Duality Biotherapeutics, Inc. ( (HK:9606) ).
Duality Biotherapeutics, Inc., a company incorporated in the Cayman Islands, has announced the full exercise of the Over-allotment Option, resulting in the issuance of 2,599,800 shares at HK$94.60 per share. This move represents approximately 15% of the total Offer Shares available under the Global Offering. The newly issued shares will facilitate the return of borrowed shares under a Stock Borrowing Agreement, used to cover over-allocations in the International Offering. The listing and trading of these shares on the Hong Kong Stock Exchange are set to commence on May 9, 2025. This development is expected to slightly adjust the company’s shareholding structure, increasing the public shareholders’ stake to 73.67%.
More about Duality Biotherapeutics, Inc.
Average Trading Volume: 1,719,989
For a thorough assessment of 9606 stock, go to TipRanks’ Stock Analysis page.